Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Teresa Graham
Pharma
Roche eyes busy 2026 despite Vabysmo miss, Tecentriq flop
Vabysmo’s CHF 1 billion sales in the fourth quarter undershot analysts’ consensus by 8%, as Roche flagged a “contraction of the U.S. branded market.”
Angus Liu
Jan 29, 2026 11:23am
Roche overcomes drug-specific struggles, currency woes in Q3
Oct 23, 2025 12:15pm
Roche's Vabysmo crosses $4B mark as Polivy joins blockbuster club
Jan 30, 2025 11:06am
Vabysmo soars as Roche grows through COVID sales declines
Feb 1, 2024 11:36am
With Polivy beat, Roche fleshes out blood cancer ambitions
Oct 19, 2023 11:28am
Roche's star eye drug Vabysmo crosses blockbuster threshold
Jul 27, 2023 11:04am
